The 2 Best Nuclear Energy Stocks to Buy in April

The article highlights a nuclear power buildout theme, citing 75 reactors under construction globally and 120 planned, with AI data-center demand and energy security as key catalysts. Cameco reported 2025 revenue growth of 11% and EPS growth of 246%, while BWX Technologies posted $3.19 billion in 2025 revenue, up 18%, with EPS up 20%. The piece is bullish on both stocks as ways to profit from the nuclear renaissance, though it is largely commentary rather than new market-moving news.

Analysis

The market is starting to price nuclear less as a commodity call and more as an infrastructure bottleneck trade. That matters because the real earnings leverage is not just higher uranium demand, but a multi-year tightening in conversion, enrichment, fuel fabrication, specialized engineering, and regulatory services — areas where incumbents with installed capacity can widen margins faster than miners. If reactor announcements keep accelerating, the scarce assets are likely to be midstream and services rather than raw ore, which argues for owning the full value chain rather than only the spot-sensitive leg.

CCJ is effectively a levered exposure to a structural capacity reset in nuclear fuel, but the easier money may already be behind it. The key second-order effect is that utility buyers with long procurement cycles will rush to secure supply before the next wave of reactor commissioning, which can support contract pricing even if spot uranium pauses. The risk is that the trade becomes crowded and any delay in reactor approvals or financing could trigger a sharp de-rating, since uranium names tend to reprice on narrative velocity more than near-term volume.

BWXT is better viewed as an arms dealer to the nuclear buildout than a pure SMR call. Even if commercial SMR deployment slips by years, naval propulsion, fuel handling, and precision nuclear components give it a much shorter monetization path than speculative reactor developers. The contrarian point is that the market may be underestimating how much of the upside is already in the “futuristic SMR” story while underappreciating the defense-adjacent contract base that can compound quietly with lower volatility.

The highest-conviction setup is to own the enablers, not the headline reactor builders. If AI-driven power demand keeps extending the utility build cycle, the biggest beneficiary may be a portfolio of nuclear supply chain names rather than a single pure-play. The main catalyst window is 6-24 months, when procurement, permitting, and capital allocation decisions start translating policy enthusiasm into actual orders.

Key Decisions for Investors

• Long CCJ on pullbacks over the next 1-3 months; use it as a medium-duration fuel scarcity trade, but trim into sharp momentum spikes because uranium equities can overshoot fundamentals quickly.
• Initiate a long BWXT position as a lower-beta nuclear infrastructure compounder; 12-24 month horizon with asymmetry from defense-backed cash flows plus optionality on SMR adoption.
• Pair trade: long BWXT / short a basket of pre-revenue SMR developers; thesis is that execution risk and dilution are being mispriced in the startups while BWXT has real earnings and regulatory credibility.
• Consider selling out-of-the-money CCJ call spreads into strength if uranium sentiment becomes euphoric; this monetizes rich implied volatility while recognizing that the core trend remains constructive.
• Watch for a catalyst basket around utility procurement announcements and DOE policy updates; add on confirmation rather than chasing headline reactor construction news.